Lv42
510 积分 2024-12-12 加入
Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial
22天前
已完结
Real-world status of multimodal treatment of stage IIIA-N2 non-small cell lung cancer in Japan: Results from the solution study, a non-interventional, multicenter cohort study
28天前
已完结
Locally advanced microsatellite instability-high esophagogastric cancer: are we ready to change our treatment paradigm?
2个月前
已完结
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
2个月前
已完结
Zolbetuximab: First Approval
2个月前
已完结
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
2个月前
已完结
Emerging targets in gastric and pancreatic cancer: Focus on Claudin 18.2
2个月前
已完结
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2个月前
已完结
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
2个月前
已完结
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2个月前
已完结
皖公网安备34019202002308
